Counselors in Tujunga, CA Accepting Medicare

6 Counselors found. Showing 1 - 6

Delina Marie Moya, CAS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 9913 Commerce Ave, Tujunga, CA 91042 Phone: 818-273-4692    Fax: 818-273-4752

Dino Jay Aguilar Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10231 Pinewood Ave, Apt 10, Tujunga, CA 91042 Phone: 818-353-1987

Leleya Khachikyan Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9832 Marnice Ave, Tujunga, CA 91042 Phone: 818-967-7127

Mrs. Alice Kevork Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10321 Wilsey Ave, Tujunga, CA 91042 Phone: 818-419-2409

Ms. Annette Oyanguren Conner Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 7762 Foothill Blvd, #217, Tujunga, CA 91042 Phone: 818-273-4676

Whitney Barnes Counselor Medicare: Not Enrolled in Medicare Practice Location: 7106 Greeley St, Tujunga, CA 91042 Phone: 323-472-0644

News Archive

SAS and EHFCN collaborate to promote awareness on healthcare fraud

SAS, the leader in business analytics software and services, will collaborate with the European Healthcare Fraud and Corruption Network (EHFCN) to spread information about detecting and preventing health care fraud. The collaboration will expose Belgium-based EHFCN to a broader European audience and identify SAS and the SAS® Fraud Framework for Health Care as a "privileged technical resource" for health care providers and insurers.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Faulty gene may identify those at risk of schizophrenia

Scientists believe they have discovered a genetic defect which could help explain the biological basis of schizophrenia.

Scientists develop new software to test alterations in night vision

Researchers from the Department of Optics of the University of Granada, belonging to the Laboratorio de Ciencias de la Visi-n y Aplicaciones, have developed a programme for testing alterations in night vision, and the tool required to implement it, which has been named "halometer".

Genetics of digestion stayed remarkably the same from fishes to humans, research shows

Scientists have discovered a network of genes and genetic regulatory elements in the lining of the intestines that has stayed remarkably the same from fishes to humans. Many of these genes are linked to human illnesses, such as inflammatory bowel diseases, diabetes and obesity.

Read more Medical News

› Verified 4 days ago